Ascentry expands its reach with the acquisition of Finbiosoft

Ascentry, global leader in data management solutions for medical laboratories, is pleased to announce the signing of an exclusivity agreement to acquire the Finnish company Finbiosoft, an editor of software solutions for medical laboratories.

Founded in 2011, Finbiosoft offers a suite of software to improve and simplify laboratory quality processes, including the solution Validation Manager, dedicated to method validation and verification.

Based in Helsinki, the company has a worldwide presence, with direct customers and distributors in 16 European countries and the USA.

Finbiosoft perfectly complements Ascentry’s offering, enabling access to extensive cross-selling opportunities. Additionally, this transaction also extends Ascentry’s reach into new markets, leveraging Finbiosoft’s established international client network.

Cyril Verhille, C.E.O of Ascentry: « This agreement with Finbiosoft marks a significant step in Ascentry’s journey to become the global reference in data management software specialized in medical laboratory industry. Following the announcement of our recent partnership with GeodAIsics in January, I am proud to see Ascentry strengthening its offering further to better serve our customers. We look forward to capitalizing on the strong base established by Akseli Virtanen and Teemu Qvick, cofounders of Finbiosoft, who remain involved in the combined group. »

Akseli Virtanen, co-founder and CEO of Finbiosoft: « Since 2011, we have been providing software that enables laboratories and diagnostic companies to enhance quality and efficiency. We truly believe in the combined proposition we have to offer and, we look forward to working together with Ascentry to continue our journey together, in the interest of our customers and to build a great future for our employees. »